Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antibacterial activity against Enterobacteriaceae assessed as inhibition of bacterial growth
Assay data:1 Tested
SummaryPubMed Citation
Antibacterial activity against Carbapenem-resistant Enterobacteriaceae EC24 assessed as fractional inhibitory concentration index incubated for 24 hrs in presence of meropenem by checkerboard assay
Antibacterial activity against NDM1 producing carbapenem-resistant Enterobacteriaceae clinical isolate 9 assessed as reduction in bacterial growth incubated for 16 to 20 hrs by CLSI-based broth microdilution method
Assay data:7 Tested
Antibacterial activity against NDM1 producing carbapenem-resistant Enterobacteriaceae clinical isolate 1 assessed as reduction in bacterial growth incubated for 16 to 20 hrs by CLSI-based broth microdilution method
Antibacterial activity against NDM1 producing carbapenem-resistant Enterobacteriaceae clinical isolate 2 assessed as reduction in bacterial growth incubated for 16 to 20 hrs by CLSI-based broth microdilution method
Antibacterial activity against NDM1 producing carbapenem-resistant Enterobacteriaceae clinical isolate 3 assessed as reduction in bacterial growth incubated for 16 to 20 hrs by CLSI-based broth microdilution method
Antibacterial activity against NDM1 producing carbapenem-resistant Enterobacteriaceae clinical isolate 4 assessed as reduction in bacterial growth incubated for 16 to 20 hrs by CLSI-based broth microdilution method
Antibacterial activity against NDM1 producing carbapenem-resistant Enterobacteriaceae clinical isolate 5 assessed as reduction in bacterial growth incubated for 16 to 20 hrs by CLSI-based broth microdilution method
Antibacterial activity against NDM1 producing carbapenem-resistant Enterobacteriaceae clinical isolate 6 assessed as reduction in bacterial growth incubated for 16 to 20 hrs by CLSI-based broth microdilution method
Antibacterial activity against NDM1 producing carbapenem-resistant Enterobacteriaceae clinical isolate 7 assessed as reduction in bacterial growth incubated for 16 to 20 hrs by CLSI-based broth microdilution method
Antibacterial activity against NDM1 producing carbapenem-resistant Enterobacteriaceae clinical isolate 8 assessed as reduction in bacterial growth incubated for 16 to 20 hrs by CLSI-based broth microdilution method
Antibacterial activity against NDM1 producing carbapenem-resistant Enterobacteriaceae clinical isolate 10 assessed as reduction in bacterial growth incubated for 16 to 20 hrs by CLSI-based broth microdilution method
Inhibition of NDM/VIM in carbapenem-resistant Enterobacteriaceae assessed as potentiation of meropenem-induced antibacterial activity by measuring meropenem MIC90 at 8 ug/ml by broth microdilution method (Rvb > 32 ug/ml)
Potentiation of meropenem-induced antibacterial activity against carbapenem-resistant Enterobacteriaceae assessed as meropenem MIC90 at 8 ug/ml by broth microdilution method (Rvb = 16 ug/ml)
Inhibition of OXA-48 in carbapenem-resistant Enterobacteriaceae assessed as potentiation of meropenem-induced antibacterial activity by measuring meropenem MIC90 at 8 ug/ml by broth microdilution method (Rvb > 32 ug/ml)
Inhibition of NDM/VIM in carbapenem-resistant Enterobacteriaceae assessed as potentiation of meropenem-induced antibacterial activity by measuring meropenem MIC50 at 8 ug/ml by broth microdilution method (Rvb = 32 ug/ml)
Potentiation of meropenem-induced antibacterial activity against carbapenem-resistant Enterobacteriaceae assessed as meropenem MIC50 at 8 ug/ml by broth microdilution method (Rvb = 8 ug/ml)
Inhibition of OXA-48 in carbapenem-resistant Enterobacteriaceae assessed as potentiation of meropenem-induced antibacterial activity by measuring meropenem MIC50 at 8 ug/ml by broth microdilution method (Rvb = 32 ug/ml)
Inhibition of NDM/VIM in carbapenem-resistant Enterobacteriaceae assessed as potentiation of ceftolozane-induced antibacterial activity by measuring ceftolozane MIC90 at 8 ug/ml by broth microdilution method (Rvb > 32 ug/ml)
Potentiation of ceftolozane-induced antibacterial activity against carbapenem-resistant Enterobacteriaceae assessed as ceftolozane MIC90 at 8 ug/ml by broth microdilution method (Rvb > 32 ug/ml)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on